DOCSLIB.ORG

0001 1 2 3 4 5 6 7 8 9 10 11 Centers for Medicare

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
0001 1 2 3 4 5 6 7 8 9 10 11 Centers for Medicare 0001 1 2 3 4 5 6 7 8 9 10 11 CENTERS FOR MEDICARE AND MEDICAID SERVICES 12 Medicare Coverage Advisory Committee 13 14 15 16 17 18 19 March 12, 2003 20 21 Baltimore Convention Center 22 100 West Pratt Street 23 Baltimore, Maryland 24 25 0002 1 Panelists 2 3 Chairperson 4 Harold C. Sox, MD 5 6 Voting Members 7 Wade M. Aubry, MD 8 Norman Daniels, PhD 9 Alan M. Garber, MD, PhD 10 Clifford Goodman, PhD 11 Tracy R. Gordy, MD 12 Mark Slaughter, MD 13 Louise Woerner 14 15 Consumer Representative 16 Linda A. Bergthold, PhD 17 18 Industry Representative 19 Eileen C. Helzner, MD 20 21 22 23 24 25 0003 1 Panelists (Continued) 2 3 Non-Voting Guest Panelists 4 George J. Agich, PhD 5 Stephen Gottlieb, MD 6 Joanne Lynn, MD, MA, MS 7 Ileana L. Pina, MD 8 Julie Swain, MD 9 10 CMS Liaison 11 Steve E. Phurrough, MD, MPA 12 13 Executive Secretary 14 Kimberly Long 15 16 17 18 19 20 21 22 23 24 25 0004 1 TABLE OF CONTENTS 2 3 Page 4 Opening Remarks 5 Kimberly Long 6 6 Steve E. Phurrough, MD, MPA 7 7 8 CMS Presentation of Request and Voting/Discussion Questions 9 Perry Bridger 13 10 11 Requestor's Presentation: Thoratec 12 Eric Rose, MD 20 13 James W. Long, MD, PhD 30 14 Leslie Miller, MD 40 15 Eric Rose, MD 48 16 17 Scheduled Public Comments 18 Mario C. Deng, MD 50 19 James K. Kirklin, MD, FACC 55 20 William A. Baumgartner, MD 59 21 Robert L. Kormos, MD 64 22 Clyde W. Yancy, MD 69 23 24 25 0005 1 TABLE OF CONTENTS (Continued) 2 3 Open Panel Deliberations 4 Lead Methodological Reviewer 5 Wade M. Aubry, MD 74 6 Lead Clinical Reviewer 7 Mark Slaughter, MD 81 8 Questions to Presenters 90 9 10 Luncheon Recess 146 11 12 Open Public Comments 13 (Waived by two speakers) 147 14 15 Open Panel Deliberations/Formal Remarks and 16 Vote 148 17 18 Discussion on discussion questions 202 19 20 Closing Remarks 21 Kimberly Long 22 23 Adjournment 24 25 0006 1 PANEL PROCEEDINGS 2 (The meeting was called to order at 8:04 a.m., 3 Wednesday, March 12, 2003.) 4 Ms. Long: Good morning and welcome, committee 5 chairperson, members and guests. I am Kimberly Long, an 6 executive secretary for the Medicare Coverage Advisory 7 Committee. The committee is here today to discuss and make 8 recommendations concerning the quality of the evidence and 9 related issues for the use of a ventricular assist device as 10 destination therapy in end-stage heart failure patients who 11 are not eligible for a heart transplant. 12 The following announcement addresses conflict of 13 interest issues associated with this meeting and is made part 14 of the record to preclude even the appearance of impropriety. 15 The conflict of interest statute prohibits special government 16 employees from participating in matters that could affect 17 their or their employers' financial interests. To determine 18 if any conflict existed, the Agency reviewed all financial 19 interests reported by the committee participants. The Agency 20 has determined that all members may participate in the 21 matters before the committee today. With respect to all 22 other participants, we ask in the interest of fairness that 23 all persons making statements or presentations disclose any 24 current or previous financial involvement with any firm whose 25 products or services they may wish to comment on. This 0007 1 includes direct financial investments, consulting fees and 2 significant institutional support. 3 Now I would like to turn the meeting over to Dr. 4 Steve Phurrough. 5 Dr. Phurrough: Thank you, Kim. I am Steve 6 Phurrough, I am the acting director for the coverage and 7 analysis group at the Center for Medicare and Medicaid 8 Services, and we want to thank all the panel members for the 9 efforts they have made to be part of this meeting today. 10 It's a very timely and exciting topic, a topic that 11 we think will generate a significant amount of discussion 12 today, and we look forward to your comments and 13 recommendations as to the evidence that's going to be 14 presented here today. 15 I want to make a special welcome to the new members 16 of the MCAC who are attending for the first time today and 17 hope you will find this a very challenging and exciting time, 18 and challenge you to be members in the future also. 19 I would like to remind the guests and the members 20 in the audience today that we do have two times for public 21 comments, one for those who have previous to this meeting 22 requested time, and then there is an open public comment time 23 period. For both groups of people, there are disclosure 24 forms that you need to have in hand that you will read prior 25 to your comments, whether it's during the scheduled time or 0008 1 during the open public time. If you don't have those forms, 2 they are out at the front desk and you can get them. 3 Again, thank you very much for your attendance, and 4 now I would like to introduce the panel chairman, Dr. Hal 5 Sox. 6 Dr. Sox: Well, we're going to start off by 7 introducing the panel members, or allowing them to introduce 8 themselves and then we'll go right into the presentation and 9 the data. 10 I'm going to, in terms of running the meeting, if 11 you'll just put your hand up when you want to be recognized, 12 I will note your name and try to take people in order. And I 13 prefer informality, so I'm going to call you by first name if 14 I can. So, what I would like to do now is have each of the 15 panel members introduce themselves by name, state your major 16 affiliation, your employer and what you do, and then it's 17 real important that you state for the public record any 18 financial interests that you have from Thoratec or a 19 competitor, and also if you've served on any other advisory 20 panel that's considered the topic of left ventricular assist 21 devices, this is the time to let everybody know about it. 22 And with the exception of the MCAC consumer and industry 23 reps, if you have been contacted by anybody with a financial 24 interest in this meeting, you should so state at this point 25 so we have that all on the public record. 0009 1 So Joanne, do you want to start? 2 Dr. Lynn: I'm Joanne Lynn. I am a physician. I 3 work with the Washington Home Center for Palliative Care 4 Studies and the Rand Corporation. I have no stock in 5 Thoratec or a competitor's company. I have no financial 6 support from Thoratec or a competitor. I don't serve on any 7 other panel that has considered this issue and I have not 8 been contacted by any party prior to the meeting to discuss 9 today's topic. 10 Dr. Gottlieb: I'm Steven Gottlieb, director of 11 heart failure and transplantation at the University of 12 Maryland. I do not have any stock or other formal financial 13 interest. I am a co-investigator of the Intrepid trial at 14 the University of Maryland. And I am not on any committees 15 and have had no contacts. 16 Dr. Sox: Anybody contacted you? 17 Dr. Gottlieb: No. 18 Dr. Pina: I'm Ileana Pina. I'm director of heart 19 failure transplant, Case Western Reserve University in 20 Cleveland and University Hospitals of Cleveland. I have no 21 stock or any financial interests in Thoratec or any 22 competitor's company, and I have no financial support from 23 Thoratec. I served on the FDA advisory panel for devices 24 which looked at and approved at the LVAD as destination 25 therapy. I have not been contacted by anyone. 0010 1 Dr. Agich: I am George Agich. I'm chairman of the 2 department of bioethics at the Cleveland Clinic Foundation. 3 I have no stock in Thoratec or a competitor company. I have 4 not received financial support from Thoratec or a competitor, 5 and I have not served on any other advisory panel and have 6 not been contacted by anyone prior to this meeting. 7 Dr. Swain: I'm Julie Swain, a cardiovascular 8 surgeon, and I serve as a consultant to the FDA and I was one 9 of the primary clinical reviewers when the REMATCH study was 10 brought to the FDA. I have no financial interests and I have 11 not been contacted by anyone with financial interests. 12 Dr. Bergthold: I'm Linda Bergthold. I'm a senior 13 consultant with Watson Wyatt Worldwide. We are consultants 14 to Fortune 1000 companies about their health benefits. And I 15 am also a researcher and participate in various research 16 projects at UC San Francisco, and I have done so in the past 17 at Stanford. I have no financial support from any of these 18 folks, I do not currently serve on any other committees, 19 although I have served on the MCAC in the past, and I have 20 not been contacted by any members of the public, which 21 actually is kind of a shame since I'm the consumer rep here, 22 but that's the truth.
Load more

Recommended publications
  • Program PDF Saturday, March 28, 2020 Updated: 02-14-20
    Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Special ‐ Events and Meetings Congenital Heart Disease ‐ Scientific Session #5002 Session #602 Fellowship Administrators in Cardiovascular Education and ACHD Cases That Stumped Me Training Meeting, Day 2 Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Saturday, March 28, 2020, 7:30 a.m. ‐ 5:30 p.m. Room S105b Marriott Marquis Chicago, Great Lakes Ballroom A CME Hours: 1.5 / CNE Hours: CME Hours: / CNE Hours: Co‐Chair: C. Huie Lin 7:30 a.m. Co‐Chair: Karen K. Stout Fellowship Administrators in Cardiovascular Education and Training Meeting, Day 2 8:00 a.m. LTGA, Severe AV Valve Regurgitation, Moderately Reduced EF, And Atrial Acute and Stable Ischemic Heart Disease ‐ Scientific Arrhythmia Session #601 Elizabeth Grier Treating Patients With STEMI: What They Didn't Teach You in Dallas, TX Fellowship! Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. 8:05 a.m. Room S505a ARS Questions (Pre‐Panel Discussion) CME Hours: 1.5 / CNE Hours: Elizabeth Grier Dallas, TX Co‐Chair: Frederick G. Kushner Co‐Chair: Alexandra J. Lansky 8:07 a.m. Panelist: Alvaro Avezum Panel Discussion: LTGA With AVVR And Reduced EF Panelist: William W. O'Neill Panelist: Jennifer Tremmel Panelist: Jonathan Nathan Menachem Panelist: Joseph A. Dearani 8:00 a.m. Panelist: Michelle Gurvitz Case of a Young Women With STEMI Panelist: David Bradley Jasjit Bhinder Valhalla, NY 8:27 a.m. ARS Questions (Post‐Panel Discussion) 8:05 a.m. Elizabeth Grier Young Women With STEMI: Something Doesn't Make Sense...
    [Show full text]
  • Newsletteralumni News of the Newyork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010
    NEWSLETTERAlumni News of the NewYork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010 CUMC 2007-2009 Transplant Activity Profile* Activity Kidney Liver Heart Lung Pancreas Baseline list at year start 694 274 174 136 24 Deceased donor transplant 123 124 93 57 11 Living donor transplant 138 17 — 0 — Transplant rate from list 33% 50% 51% 57% 35% Mortality rate while on list 9% 9% 9% 15% 0% New listings 411 217 144 68 23 Wait list at year finish 735 305 204 53 36 2007-June 2008 Percent 1-Year Survival No % No % No % No % No % Adult grafts 610 91 279 86 169 84 123 89 6 100 Adult patients 517 96 262 88 159 84 116 91 5 100 Pediatric grafts 13 100 38 86 51 91 3 100 0 — Pediatric patients 11 100 34 97 47 90 2 100 0 — Summary Data Total 2009 living donor transplants 155 (89% Kidney) Total 2009 deceased donor transplants 408 (30% Kidney, 30% Liver) 2007-June 2008 adult 1-year patient survival range 84% Heart to 100% Pancreas 2007-June 2008 pediatric 1-year patient survival range 90% Heart to 100% Kidney or lung *Health Resource and Service Administration’s Scientific Registry of Transplant Recipients (SRTR) Ed Note. The figure shows the US waiting list for whole organs which will only be partially fulfilled by some 8,000 deceased donors, along with 6,600 living donors, who will provide 28,000 to 29,000 organs in 2010. The Medical Center’s role in this process is summarized in the table, and the articles that follow my note expand on this incredible short fall and its potential solutions.
    [Show full text]
  • Newsletteralumni News of the Newyork-Presbyterian Hospital/Columbia University Department of Surgery Volume 12 Number 1 Spring 2009
    NEWSLETTERAlumni News of the NewYork-Presbyterian Hospital/Columbia University Department of Surgery Volume 12 Number 1 Spring 2009 Outliers All requires several iterative improvements and sometimes a leap of faith to cross a chasm of doubt and disappointment. This process is far more comfortable and promising if it is imbued with cross- discipline participation and basic science collaboration. Eric’s early incorporation of internist Ann Marie Schmidt’s basic science group within his Department continues to be a great example of the pro- ductivity that accrues from multidiscipline melding. Several speakers explored training in and acceptance of new techniques. The private practice community led the way in training and early adoption of laparoscopic cholecystectomy, which rapidly supplanted the open operation, despite an early unacceptable inci- dence of bile duct injuries. Mini-thoracotomies arose simultaneous- ly at multiple sites and are now well accepted as viable approaches to the coronaries and interior of the heart; whereas, more than a de- cade after their introduction, video assisted lobectomies for stage I, non-small-cell lung cancer account for <10% of US lobectomies. Os- tensibly, this reluctance reflects fear of uncontrollable bleeding and not doing an adequate cancer operation, neither of which has been a problem in the hands of VATS advocates. The May 8, 2009, 9th John Jones Surgical Day was a bit of an Lesions that are generally refractory to surgical treatment, outlier because the entire day was taken up by a single program, ex- such as glioblastomas and esophageal and pancreas cancers merit cept for a short business meeting and a lovely evening dinner party.
    [Show full text]
  • NEWSLETTER Alumni News of the Newyork-Presbyterian Hospital/Columbia University Department of Surgery
    Volume 10, Number 1 Summer 2007 John Jones Sur gical Society NEWSLETTER Alumni News of the NewYork-Presbyterian Hospital/Columbia University Department of Surgery John Jones Surgical Society 2007 Symposium: Dick Edie, Dave Carberry, Lou Del Guercio, Jack Jacobson, Sherman Bull, Craig Smith, and John Schullinger listening to a question from the floor with varying intensity Editor: James G Chandler Administrator: Trisha J. Hargaden Photography and Design: Jada Fabrizio John Jones Surgical Society • 177 Fort Washington Avenue, MHB 7SK, New York, NY 10032 Tel: 212-305-2735 • Fax: 212-305-3236 • webpage: www.columbiasurgery.org/alumni/index.html John Jones 7th Annual Surgical Society Day Symposium presenters; Murray Brennan, Kenneth Forde, Robert Touloukian, Richard Craig Smith and Ken Forde Reznick with moderator José Guillem Surgical residents enjoying lunch Alex Iribarne, Keith Kuenzler (faculty), Ryan Davies, Brian Cohen, John Jones Surgical Society opens its doors to medical students Audrey Rosinberg, and Amanda Powers Warren Widmann Prashant Sinha, Bob Smith and Bob Mulcare Soji Oluwole and Hector DePaz Chief Surgical Resident Jean Emond and Benjamin Samstein Herbert Mendel, Anne Larkin and Carey Dolgin Gabriel Toma, (Post Doctoral Research Scientist) with Maurizio Miglietta Steve Novak and Marianne Wolffe Spencer Amory Alan Benvenisty and Ruth Hardy Charlie Stolar John Jones Surgical Society Volume 10, Number 1 Summer 2007 3 John Jones Surgical Society Day At The NewYork-Presbyterian Hospital/Columbia Campus James G. Chandler with considerable
    [Show full text]
  • Preliminary Program
    INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION Twenty-Second Annual Meeting and Scientific Sessions Final Program April 10-13, 2002 Convening at the Hilton Washington and Towers, Washington, DC PRESIDENT James B. Young, MD, Cleveland, OH PRESIDENT-ELECT Stephan Schueler, MD, Newcastle Upon Tyne, United Kingdom PAST PRESIDENT Anne Keogh, MBBS, MD, Sydney, Australia SECRETARY/TREASURER Alec Patterson, MD, St. Louis, MO DIRECTORS Robert C. Bourge, MD, Birmingham, AL Paul A. Corris, MB, FRCP, Newcastle Upon Tyne, United Kingdom F. Jay Fricker, MD, Gainesville, FL Axel Haverich, MD, Hannover, Germany Luigi Martinelli, MD, Genova, Italy Mehmet C. Oz, MD, New York, NY Sabina M. De Geest, RN, PhD, Basel, Switzerland W. Steves Ring, MD, Dallas, TX Robert C. Robbins, MD, Stanford, CA David O. Taylor, MD, Cleveland, OH Adriana Zeevi, PhD, Pittsburgh, PA JHLT EDITOR James K. Kirklin, MD, Birmingham, AL HEART AND LUNG TRANSPLANT REGISTRY MEDICAL DIRECTOR Marshall I. Hertz, MD, Minneapolis, MN MECHANICAL CIRCULATORY SUPPORT DEVICE DATABASE MEDICAL DIRECTOR Mario Deng, MD, New York, NY STAFF Amanda W. Rowe, Executive Director Phyllis Glenn, Director of Membership Services Lisa Edwards, Director of Meetings LeeAnn Mills, Director of Operations 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION PAST PRESIDENTS 1981-1982 Michael Hess, MD 1982-1984 Jack Copeland, MD 1984-1986 Terence English, FRCS 1986-1988 Stuart Jamieson, MD 1988-1990 Bruno Reichart, MD 1990-1991 Margaret Billingham, MD 1991-1992 Christian Cabrol, MD 1992-1993 John O’Connell, MD 1993-1994 Eric Rose, MD 1994-1995 John Wallwork, FRCS 1995-1996 Sharon Hunt, MD 1996-1997 William Baumgartner, MD 1997-1998 Leslie Miller, MD 1998-1999 Alan Menkis, MD, FRCS(C) 1999-2000 Robert L.
    [Show full text]
  • Historical Perspectives of Mechanical Cardiac Assist
    HISTORICAL PERSPECTIVES OF MECHANICAL CARDIAC ASSIST Rohinton J. Morris, MD Chief- Cardiothoracic Surgery, Abington-Jefferson Health Systems PROGRAM • Past – From inception to clinical use • Present – Devices, patients & outcomes • Future – Technology, management & directions THE BEGINNING EARLY HORIZON OF CARDIAC SURGERY • 1949-Bailey, Harken surgically treat mitral stenosis • 1954- Gibbon introduces the heart-lung machine • Late 50’s- multiple tissue substitutes/homografts in desc aorta • 1960-Starr’s caged ball valve BACKGROUND • 1962. .Kennedy is President, declares that man will land on the moon this decade, and faces nuclear war with the Cuban missile crisis. • …John Glenn orbits the earth • …1st Kmart is opened • …Wilt Chamberlain scores a 100 pts in a game • …3 Boeing 707’s have fatal crashes • …The Rolling Stones debut & Marilyn Monroe dies • …Mariner2 flies by Venus, transmitting 1st data from another planet. • …Watson, Crick & Wilkins win the Nobel prize in medicine for the structure of DNA • …Norman Shumway is transplanting animal hearts… EARLY PIONEERS • 1964- U.S. Artificial Heart Program (LBJ) • Drs. DeBakey and Kolff • “The Heart is a Pump” • NHI morphs into NHLBI • 1967 – Barnaard, Shumway leadthe world into heart transplantation HISTORY- MCS/DT • VADs began as an additive technology • Transplant List Mortality was too high • “Assist” was the key word • “Whether permanent, mechanical, orthotopic replacement of the heart will be feasible or practical remains a moot question” Cooley 2001 Cooley -1969 w/Liotta heart First
    [Show full text]
  • Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=13237 Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary ISBN Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; 978-0-309-21929-7 Forum on Drug Discovery, Development, and Translation; Institute of Medicine 140 pages 8 1/2 x 11 PAPERBACK (2011) Visit%the%National%Academies%Press%online%and%register%for... Instant&access&to&free&PDF&downloads&of&titles&from&the NATIONAL&ACADEMY&OF&SCIENCES NATIONAL&ACADEMY&OF&ENGINEERING INSTITUTE&OF&MEDICINE NATIONAL&RESEARCH&COUNCIL 10%&off&print&titles Special&offers&and&discounts Distribution,&posting,&or&copying&of&this&PDF&is&strictly&prohibited&without&written&permission&of&the&National&Academies&Press.& Unless&otherwise&indicated,&all&materials&in&this&PDF&are&copyrighted&by&the&National&Academy&of&Sciences.& Request&reprint&permission&for&this&book Copyright&©&National&Academy&of&Sciences.&All&rights&reserved. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy Copyright © National Academy of Sciences. All rights reserved. Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Govern- ing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineer- ing, and the Institute of Medicine.
    [Show full text]
  • If I Only Had a …
    B ODYBUILDING:THE B IONIC H UMAN I NTRODUCTION If I Only Had a … could stay young and chipper and I’d lock it with a zipper, if I only had a heart,” “ sang the Tin Man to his companions in the 1939 movie The Wizard of Oz. There is hope yet for the Tin Man and for the many thousands of patients with diseased hearts, damaged livers, or injured tissues. Spurred on by a severe shortage of donor organs for transplantation, bioengineers, cell biologists, and clinicians are combining their tal- ents to design off-the-shelf replacement parts for the human body. This dream is not Inew, as our historical timeline on the next two pages reveals. A daring goal that has captured the public imagination is the implantation of a totally artificial heart into patients with end-stage heart failure (p. 1000), a remarkable achievement despite recent setbacks. Of simpler design, ven- CONTENTS tricular assist devices, which support the left ventricle until the heart repairs it- self, may benefit the majority of patients with heart disease (p. 998). Similar- 998 Mechanical Circulatory Support ly, a bioartificial liver device, composed of liver cells nurtured in a bioreactor, —a Long and Winding Road P. M. McCarthy and W. A. Smith is undergoing clinical testing as a bridge to support the failing liver until it can regenerate (p. 1005). Meanwhile, despite numerous regulatory hurdles 1000 A Space Age Vision Advances in (p. 1003), researchers are developing artificial blood substitutes (p. 1002) for the Clinic use instead of donor blood during lengthy surgeries or at disaster sites.
    [Show full text]
  • 2003 Final Program
    The International Society for Heart and Lung Transplantation Twenty-Third Annual Meeting and Scientific Sessions April 9-12, 2003 Convening at the Hofburg Congress Center Vienna, Austria Final Program Board of Directors President Stephan Schueler, MD, Newcastle, United Kingdom President-Elect Jon Kobashigawa, MD, Los Angeles, CA Past President James B. Young, MD, Cleveland, OH Secretary/Treasurer Alec Patterson, MD, St. Louis, MO Directors Paul A. Corris, MB, FRCP, Newcastle, United Kingdom Sabina M. De Geest, RN, PhD, Basel, Switzerland F. Jay Fricker, MD, Gainesville, FL Luigi Martinelli, MD, Genova, Italy Soon J. Park, MD, Minneapolis, MN Hermann Reichenspurner, MD, PhD, Hamburg, Germany W. Steves Ring, MD, Dallas, TX Robert C. Robbins, MD, Stanford, CA Heather J. Ross, MD, Toronto, Canada David O. Taylor, MD, Cleveland, OH Adriana Zeevi, PhD, Pittsburgh, PA JHLT Editor James K. Kirklin, MD, Birmingham, AL Heart and Lung Transplant Registry Medical Director Marshall I. Hertz, MD, Minneapolis, MN Mechanical Circulatory Support Device Database Medical Director Mario C. Deng, MD, New York, NY Staff Amanda W. Rowe Executive Director Phyllis Glenn Assistant Executive Director Director of Membership Services Lisa Edwards Director of Meetings LeeAnn Mills Director of Operations 14673 Midway Road, Suite 200 Addison, TX 75001 Phone: 972-490-9495 Fax: 972-490-9499 www.ishlt.org [email protected] PAST PRESIDENTS 1981-1982 Michael Hess, MD 1982-1984 Jack Copeland, MD 1984-1986 Terence English, FRCS 1986-1988 Stuart Jamieson, MD 1988-1990 Bruno Reichart, MD 1990-1991 Margaret Billingham, MD 1991-1992 Christian Cabrol, MD 1992-1993 John O’Connell, MD 1993-1994 Eric Rose, MD 1994-1995 John Wallwork, FRCS 1995-1996 Sharon Hunt, MD 1996-1997 William Baumgartner, MD 1997-1998 Leslie Miller, MD 1998-1999 Alan Menkis, MD, FRCS(C) 1999-2000 Robert L.
    [Show full text]
  • HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 & BARDA Industry Day Participants
    HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 & BARDA Industry Day Participants September 24−26, 2008 Crystal Gateway Marriott Arlington, VA U.S. Department of Health and Human Services Assistant Secretary for Preparedness and Response Biomedical Advanced Research and Development Authority inside front cover blank PARTICIPANTS M. Javad Aman, PhD President and Chief Scientific Officer Katherine (Kay) Aaby, RN, BSN, MPH Integrated BioTherapeutics Inc. Nurse Manager [email protected] Montgomery County, Maryland Department of Health and Human Services Norman Anderson, PhD [email protected] President Viral Defense Foundation Abe Abramovich, BSEE, MSEE [email protected] Spacelabs Healthcare [email protected] Richard Andrews, BS, MS, SM David Adams, BSN, MA Chief Business Officer Director, Contingency Planning and Policy ProThera Biologics Office of Health Affairs [email protected] U.S. Department of Homeland Security [email protected] Russell Andrews, MS, RPh Chief Executive Officer Steven Adams, MPH NexGenisys Deputy Director [email protected] Division of Strategic National Stockpile Coordinating Office for Terrorism Preparedness and Edward Arcuri, PhD Emergency Response Chief Operating Officer Centers for Disease Control and Prevention VaxInnate U.S. Department of Health and Human Services [email protected] [email protected] Mary Ari, PhD Heidi Agostini, PhD, PMP Health Scientist Associate Director Centers for Disease Control and Prevention Botulinum Vaccine and Therapeutic Programs U.S. Department of Health and Human Services Emergent Product Development, Inc. [email protected] [email protected] Alexander Aristarkhov, PhD Ronald Aimes, PhD Director, Science & Technology Associate Director, Research and Development Exiqon, Inc. Peregrine Pharmaceuticals, Inc.
    [Show full text]
  • CV-Mario-Deng.Pdf
    CURRICULUM VITAE Mario Chih-Hsiung Karl Deng, MD 1) February 16, 2011 2) Personal Data Name Mario Chih-Hsiung Karl Deng Date of Birth March 28, 1955 Place of Birth Berlin, Germany Citizenship German US-Visa Status Permanent Residency (Outstanding Researcher Category) 3) Education/Academic Training 1965-1974 Humanistic (Ancient Greek/Latin) Grammar School Hansa-Gymnasium Hamburg & Graduation (German Grade Point Average 1.5) 1971-1972 Student Exchange, Bolsa Grande High School, Los Angeles, Ca, USA, Honor Roll, Debater of the Year, Graduation with „A“ Grade Point Average 1974-1976 Preclinical Studies, Medical School, Hamburg University, Germany 1976-1981 Clinical Studies, Medical School, Berlin Free University, Germany 1981 State Examination as a Doctor 1988 Medical Thesis and Doctoral Degree ("Cum Laude") 1996 Habilitation in Internal Medicine and Cardiology (Requirement for German full Professorship) 4) Postdoctoral Training 1981-1982 Internship in Internal Medicine, General Hospital Soltau 1982-1986 Residency in Internal Medicine, General Hospital Soltau and Mary’s Hospital Bottrop, Germany 1986-1988 Residency in Radiology, Miners Hospital Bottrop, Germany 1988-1992 Fellowship in Cardiology, Duisburg Heart Institute, Germany Curriculum Vitae, Page 2 Mario C. Deng, MD 1992-1993 Postdoctoral Fellowship, Division of Cardiovascular Medicine (Chief Victor J Dzau MD), Stanford University, USA (Molecular Biology Laboratory Hannah A Valantine MD and Cardiac Transplantation Program Sharon A Hunt MD) 5) Licensure/Board Qualification 1981 Licensure/Registration
    [Show full text]
  • 1992 Annual Meeting Program
    1992 ANNUAL MEETING PROGRAM THE AMERICAN ASSOCIATION FOR THORACIC SURGERY 1991 -1992 President John A. Waldhausen, Hershey, PA Vice-President John L. Ochsner, New Orleans, LA Secretary Martin F. McKneally, Toronto, Ontario,Canada Treasurer William A. Gay, Jr., Salt Lake City, UT Editor John W. Kirklin, Birmingham, AL Councilors Delos M. Cosgrove (1994), Cleveland, OH Tom R. Demeester (1993), Los Angeles, CA L.Henry Edmunds, Jr. (1992), Philadelphia, PA Robert A. Guyton (1995), Atlanta, GA Keith Reemtsma (1992), New York, NY Membership Committee William G. Williams, Chairman, Toronto,Ontario, Canada Delos M. Cosgrove, Cleveland, OH Eddie L. Hoover, Buffalo, NY Alex G. Little, Las Vegas, NV M. Terry McEnany, San Francisco, CA William S. Pierce, Hershey, PA Eric W. Rose, New York, NY Association Representatives, Board of Governors, The American Board of Thoracic Surgery Richard J. Cleveland, Boston, MA Fred A. Crawford, Jr., Charleston, SC John A. Waldhausen, Hershey, PA Benson R. Wilcox, Chapel Hill, NC Floyd D. Loop (1994), Cleveland, OH Harold V. Liddle (1993), Salt Lake City, UT THE AMERICAN ASSOCIATION FOR THORACIC SURGERY 1992 Annual Meeting COMMITTEES LOCAL ARRANGEMENTS Donald G. Mulder, M.D., Chairman E. Carmack Holmes, M.D. Richard K. Hughes, M.D. George G. Lindesmith, M.D. James V. Maloney, Jr., M.D. LADIES' HOSPITALITY COMMITTEE Mrs. Donald G. Mulder, Committee Chairwoman Mrs. E. Carmack Holmes Mrs. Richard K. Hughes Mrs. George G. Lindesmith Mrs. James V. Maloney, Jr. PROGRAM COMMITTEE Chairman, John A. Waldhausen, M.D.................................... Hershey, Pennsylvania John W. Kirklin, M.D................................................................... Birmingham, Alabama Martin F. McKneally, M.D.................................................................. Toronto, Ontario John L.
    [Show full text]